ClinicalTrials.Veeva

Menu

Study of the Role of Hemostasis in Perioperative Anaphylaxis (HEMOCANOPE)

U

University Hospital, Strasbourg, France

Status

Unknown

Conditions

Perioperative Complication
Hemoptysis
Anaphylaxis

Study type

Observational

Funder types

Other

Identifiers

NCT04825158
8030 (Other Identifier)

Details and patient eligibility

About

Anaphylaxis is a severe and life-threatening complication during the perioperative period. Perioperative anaphylaxis is still associated with a significant mortality despite quick and efficient management using epinephrine, the mainstay of acute treatment. Experimental data and few case reports are suggesting that hemostasis, and more precisely platelets, could play a role in anaphylaxis. Our main hypothesis is that activation of the hemostatic system contributes to the severity of the reaction

Enrollment

30 estimated patients

Sex

All

Ages

2+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient, male or female, adult
  • In the perioperative period
  • In whom the diagnosis of anaphylactic shock is suggested
  • Patient is giving his consent to participate in the study

Exclusion criteria

  • Subject under legal protection
  • Subject under guardianship or guardianship
  • Anemia less than 7 g /dl at the time of inclusion

Trial contacts and locations

0

Loading...

Central trial contact

Charles-Ambroise TACQUARD, PHD; Xavier DELABRANCHE, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems